Literature DB >> 24768111

New era for treatment in differentiated thyroid cancer.

Sigurdis Haraldsdottir1, Manisha H Shah2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24768111     DOI： 10.1016/S0140-6736(14)60663-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Efficacy of sorafenib and impact on cardiac function in patients with thyroid cancer: a retrospective analysis.

Authors:  L Mortara; G Pera; E Monti; S Morbelli; F Minuto; G Sambuceti; M Giusti
Journal:  J Endocrinol Invest       Date:  2014-10-05       Impact factor: 4.256

2.  Transcriptomic signature associated with carcinogenesis and aggressiveness of papillary thyroid carcinoma.

Authors:  Huajing Teng; Fengbiao Mao; Jialong Liang; Meiying Xue; Wenqing Wei; Xianfeng Li; Kun Zhang; Dongdong Feng; Baoguo Liu; Zhongsheng Sun
Journal:  Theranostics       Date:  2018-07-30       Impact factor: 11.556
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.